{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenovirus+Infections", "query": { "condition": "Adenovirus Infections" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 200, "total_pages": 20, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Adenovirus+Infections&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-27T06:12:04.855Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00392015", "title": "NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Plasmodium Falciparum" ], "interventions": [ { "name": "NMRC-M3V-Ad-PfCA", "type": "BIOLOGICAL" }, { "name": "NMRC-MV-Ad-PfC, NMRC-M3V-Ad-PfCA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "U.S. Army Medical Research and Development Command", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 59, "start_date": "2006-10-12", "completion_date": "2017-09-25", "has_results": true, "last_update_posted_date": "2021-05-21", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00392015" }, { "nct_id": "NCT02596997", "title": "Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease", "overall_status": "NO_LONGER_AVAILABLE", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Adenovirus" ], "interventions": [ { "name": "Brincidofovir", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": null, "eligibility": { "minimum_age": "2 Months", "maximum_age": null, "sex": "ALL", "summary": "2 Months and older" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2022-03-14", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 46, "location_summary": "Little Rock, Arkansas • Los Angeles, California • Orange, California + 33 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02596997" }, { "nct_id": "NCT01011712", "title": "The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "EBV", "HSV", "VZV", "HPV", "CMV" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "2 Years to 100 Years" }, "enrollment_count": 600, "start_date": "2009-10-01", "completion_date": null, "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT01011712" }, { "nct_id": "NCT05213728", "title": "A Phase 1, Open-label, Safety and Immunogenicity Study of an Oral Multi-dose Administration Regimen With an Adenoviral-vector Based Tablet Norovirus Vaccine (VXA-G1.1-NN) Administered to Healthy Adult Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Norovirus Infections" ], "interventions": [ { "name": "VXA-G1.1-NN", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Vaxart", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 8, "start_date": "2022-01-24", "completion_date": "2022-02-24", "has_results": false, "last_update_posted_date": "2024-06-21", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05213728" }, { "nct_id": "NCT02543567", "title": "A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ad26.ZEBOV 5*10^10 viral particles (vp)", "type": "BIOLOGICAL" }, { "name": "Ad26.ZEBOV 2*10^10 (vp)", "type": "BIOLOGICAL" }, { "name": "Ad26.ZEBOV 0.8*10^10 (vp)", "type": "BIOLOGICAL" }, { "name": "MVA-BN-Filo 1*10^8 Infectious Unit [Inf. U.]", "type": "BIOLOGICAL" }, { "name": "MVA-BN-Filo 5*10^7 Inf. U.", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Janssen Vaccines & Prevention B.V.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 525, "start_date": "2015-09-21", "completion_date": "2016-11-29", "has_results": false, "last_update_posted_date": "2025-05-25", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 6, "location_summary": "Huntsville, Alabama • San Diego, California • Melbourne, Florida + 3 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "San Diego", "state": "California" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Mishawaka", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02543567" }, { "nct_id": "NCT00080106", "title": "Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "MRK Ad5 HIV-1 gag vaccine", "type": "BIOLOGICAL" }, { "name": "Vaccine placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 114, "start_date": "2004-06", "completion_date": "2011-05", "has_results": false, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 27, "location_summary": "Los Angeles, California • Palo Alto, California • Sacramento, California + 19 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00080106" }, { "nct_id": "NCT00942409", "title": "Study of Repeat Intranodal Injections of Ad-ISF35", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Hodgkin's Lymphoma", "Follicular Lymphoma", "Diffuse Large Cell Lymphoma", "Mantle Cell Lymphoma", "Small Lymphocytic Lymphoma", "Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "ISF35", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Januario Castro, M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 5, "start_date": "2009-06", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2015-12-30", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00942409" }, { "nct_id": "NCT00479999", "title": "Phase 1 Safety Study of Two Experimental HIV Vaccines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "AIDS Vaccines", "HIV Infections", "HIV-1" ], "interventions": [ { "name": "VRC-HIVADV027-00-VP", "type": "DRUG" }, { "name": "VRC-HIVADV038-00-VP", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 35, "start_date": "2007-05-24", "completion_date": "2014-05-05", "has_results": false, "last_update_posted_date": "2019-12-16", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00479999" }, { "nct_id": "NCT05101213", "title": "Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Adenovirus Infection", "BK Virus Infection", "Cytomegaloviral Infection", "Hematopoietic and Lymphoid Cell Neoplasm", "JC Virus Infection", "Malignant Solid Neoplasm", "Symptomatic COVID-19 Infection Laboratory-Confirmed" ], "interventions": [ { "name": "Virus-specific Cytotoxic T-lymphocytes", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2023-01-06", "completion_date": "2027-01-31", "has_results": false, "last_update_posted_date": "2026-04-16", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05101213" }, { "nct_id": "NCT00787059", "title": "AC6 Gene Transfer for CHF", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Congestive Heart Failure" ], "interventions": [ { "name": "Ad5.hAC6", "type": "DRUG" }, { "name": "Sucrose (3%)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hammond, H. Kirk, M.D.", "sponsor_class": "INDIV", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 56, "start_date": "2010-07", "completion_date": "2017-11-16", "has_results": false, "last_update_posted_date": "2018-02-09", "last_synced_at": "2026-06-27T06:12:04.855Z", "location_count": 7, "location_summary": "San Diego, California • Chicago, Illinois • Minneapolis, Minnesota + 3 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00787059" } ] }